Cardiovascular risk factors in relation to cigarette smoking: A population-based survey among Asians in Singapore

Atherosclerosis

Volumn 137, Issue 2, 1998, Pages 253-258

  Hughes, Kenneth ^a   Choo, Maurice ^b   Kuperan, Ponnudurai ^c   Ong, Choon Nam ^a   Aw, Tar Choon ^d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b MOUNT ELIZABETH MEDICAL CENTRE   (Singapore)

^c TAN TOCK SENG HOSPITAL   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Anti oxidants; Atherosclerosis; Insulin resistance; Lipids; Lipoproteins; Pro oxidants; Thrombosis

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; SELENIUM; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY RISK; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MALE; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SINGAPORE; THROMBOSIS;

ADULT; AGED; ANTIOXIDANTS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; ETHNIC GROUPS; FIBRINOGEN; HUMANS; INSULIN; LIPIDS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREVALENCE; QUESTIONNAIRES; RANDOM ALLOCATION; REACTIVE OXYGEN SPECIES; RETROSPECTIVE STUDIES; RISK FACTORS; SINGAPORE; SMOKING;

EID: 17444451087     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00268-2     Document Type: Article

References (26)

1. Castelli WP Lipids, risk factors and ischaemic heart disease. Atherosclerosis. 124:1996;S1-9.
2. Pyorala K, Iaakso M, Uusitupa M Diabetes and atherosclerosis an epidemiologic view. Diabetes Metab Rev. 3:1987;463-524.
3. Nordoy A Haemostatic factors in coronary heart disease. J Intern Med. 233:1993;377-383.
4. Juhan-Vage I Haemostatic parameters and vascular risk. Atherosclerosis. 124:1996;S49-55.
5. Lip GY, Jones AF Lipoprotein(a) and vascular disease: thrombosis and atherogenesis. Q J Med. 88:1995;529-539.
6. Halliwell B Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet. 344:1994;721-724.
7. Burt MJ, Halliday JW, Powell LW Iron and coronary heart disease. Br Med J. 307:1993;575-576.
8. Hughes K, Aw TC, Kuperan P, Choo M Central obesity, insulin resistance, syndrome X, lipoprotein(a) and cardiovascular risk in Indians, Malays, and Chinese in Singapore. J Epidemiol Community Health. 51:1997;394-399.
9. Hughes K, Lun KC, Yeo PBB Cardiovascular diseases in Chinese, Malays, and Indians in Singapore. I. Differences in mortality. J Epidemiol Community Health. 44:1990;24-28.
10. World Health Organization. Multinational monitoring of trends and determinants in cardiovascular diseases, 'Monica Project': Manual of Operations. Geneva: World Health Organization, 1982.
11. Liau LS, Lee BL, New AL, Ong CN Determination of plasma ascorbic acid by high-performance liquid chromatography with ultraviolet and electrochemical detection. J Chromatogr. 612:1993;63-70.
12. Lee BL, Chua SC, Ong HY, Ong CN High-performance liquid chromatographic method for routine determination of vitamins A and E and beta-carotene in plasma. J Chromatogr. 581:1992;41-47.
13. WHO Study Group Prevention of diabetes mellitus. Who Tech Rep Ser. 844:1994;1-100.
14. WHO Study Group on Diabetes Mellitus Diabetes Mellitus. WHO Tech Rep Ser. 727:1985;1-113.
15. Hughes K, Leong WP, Sothy SP, Lun KC, Yeo PPB Relationships between cigarette smoking, blood pressure and serum lipids in the Singapore general population. Int J Epidemiol. 22:1993;637-643.
16. Craig MH, Palomaki GE, Haddow JE Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. Br Med J. 298:1989;784-788.
17. Gerace TA, Hollis J, Ockene JK, Svendsen K Smoking cessation and change in diastolic blood pressure, body weight, and plasma lipids. MRFIT Research Group. Prev Med. 20:1991;612-620.
18. Blache D, Bouthillier D, Davignon J Acute influence of smoking on platelet behaviour, endothelium and plasma lipids and normalisation by Aspirin. Atherosclerosis. 93:1992;179-188.
19. Fievet C, Fruchart JC HDL heterogeneity and coronary heart disease. Diabetes Metab Rev. 7:1991;155-162.
20. Wiman B Plasminogen activator inhibitor 1 (PAI-1) in plasma: Its role in thrombotic disease. Thromb Haemostas. 74:1995;71-76.
21. Naslund GK, Fredrikson M, Hellenius ML, de-Faire U Effect of diet and physical exercise intervention programmes on coronary heart disease risk in smoking and non-smoking men in Sweden. J Epidemiol Community Health. 50:1996;131-136.
22. Reaven GM Role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
23. Reaven GM Pathophysioogy of insulin resistance in human disease. Physiol Rev. 75:1995;473-486.
24. Fucchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM Insulin resistance and cigarette smoking. Lancet. 339:1992;1128-1130.
25. Jacob RA. Vitamin C. In: Shils ME, Olson JA, Shike M, editors. Modern Nutrition in Health and Disease. Philadelphia, PA: Lea and Febiger, 1994:432-48.
26. Levander OA, Burk RF. Selenium. In: Shils ME, Olson JA, Shike M, editors. Modern Nutrition in Health and Disease. Philadelphia, PA: Lea and Febiger, 1994:242-51.